PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The extend of skin fibrosis in scleroderma patients is currently assessed using the semi-quantitative modified Rodnan skin score (mRSS) which is an assessment of skin thickness. We investigated the use of spatial frequency domain imaging (SFDI) for more quantitative and reliable assessment of skin fibrosis. SFDI measurements were conducted at 6 body locations of 10 control subjects and 10 patients with scleroderma. SFDI results, especially reduced scattering coefficient, show strong correlation with the mRSS score measured by the physician at the same body locations suggesting that SFDI is a reliable tool to quantify skin fibrosis in scleroderma patients.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Anahita Pilvar, Andreea Bujor, Darren Roblyer, "Spatial frequency domain imaging (SFDI) to quantify skin fibrosis in patients with scleroderma," Proc. SPIE PC11934, Photonics in Dermatology and Plastic Surgery 2022, PC1193402 (7 March 2022); https://doi.org/10.1117/12.2608182